My Macular and Me webinars

Every month we host an exciting new webinar to bring you closer to the experts. We are joined by experts in macular disease who discuss the latest in treatments and research and answer your questions.

Register for our monthly webinars

Our monthly webinar takes place on the third Tuesday of every month at 7pm, with a focus on topics for patients with age-related macular degeneration (AMD).

Please share any questions you would like our guests to address in our upcoming webinars. Send them to mymacularandme@macularsociety.org.

Update in treatments for macular degeneration and what to expect in 2025

Lytenava (bevacizumab gamma), is the first licensed version of Avastin for wet age-related macular degeneration. The treatment was approved by the National Institute for Health and Care Excellence (NICE) for use in the NHS last year.

Join our monthly webinar as professor Andrew Lotery will break down what this new treatment means for you. He’ll also discuss how Lytenava compares to existing treatments, such as Eylea and Lucentis, its potential benefits, and what this approval means for NHS patients.

This webinar will be taking place at 7pm on Tuesday 21 January.